The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development
Background Progestin-only pills (POPs) have been used for contraception in breastfeeding women for years. The existing guidelines allow the use of these contraceptives.Methods Multicenter study with a single visit and retrospective data review. The study involved 100 women who used a drospirenone-on...
Saved in:
| Main Authors: | Pedro Antonio Regidor, Enrico Colli, Artur Jakimiuk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Gynecological Endocrinology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2024.2382800 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and evidence base of a combined oral contraceptive based on estherol and drospirenone: a brief summary
by: Mekan R. Orazov, et al.
Published: (2024-09-01) -
Effects of Continuous Use of Oral Drospirenone/Estradiol on Lipid Profile, Body Weight, and BP in Females from Early Menopause
by: Roshan Mandloi, et al.
Published: (2025-05-01) -
"Neutrality in everything," or "endocrine-metabolic nocturne" of the combined oral contraceptive based on E4/drospirenone: A review
by: Mekan R. Orazov, et al.
Published: (2025-01-01) -
CARDIOPROTECTIVE PROPERTIES OF PROGESTINES: INFLUENCE OF DROSPIRENONE ON MYOCARD IN EXPERIMENTAL HEART FAILURE
by: Yu. V. Liskova, et al.
Published: (2017-07-01) -
Safety and tolerability of a combined oral contraceptive containing estetrol/drospirenone in real-life clinical practice: An open-label, prospective, multicenter, epidemiological, observational program "Estetiko"
by: Natalia V. Aganezova, et al.
Published: (2025-01-01)